Literature DB >> 8364008

Verapamil prevents sudden death in patients with increased heart size after an acute myocardial infarction.

J F Hansen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8364008     DOI： 10.1007/bf00880163

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN： 0920-3206            Impact factor:   3.727


× No keyword cloud information.
  5 in total

Review 1.  Should calcium antagonists be used after myocardial infarction? Ischemia selectivity versus vascular selectivity.

Authors:  L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1992-02       Impact factor: 3.727

2.  The effect of diltiazem on mortality and reinfarction after myocardial infarction.

Authors: 
Journal:  N Engl J Med       Date:  1988-08-18       Impact factor: 91.245

3.  Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish Verapamil Infarction Trial II--DAVIT II)

Authors: 
Journal:  Am J Cardiol       Date:  1990-10-01       Impact factor: 2.778

4.  Calcium antagonists and cardiac noradrenaline release in ischemia.

Authors:  G Richardt; M Haass; A Schömig
Journal:  J Mol Cell Cardiol       Date:  1991-03       Impact factor: 5.000

5.  Secondary prevention reinfarction Israeli nifedipine trial (SPRINT). A randomized intervention trial of nifedipine in patients with acute myocardial infarction. The Israeli Sprint Study Group.

Authors: 
Journal:  Eur Heart J       Date:  1988-04       Impact factor: 29.983
  5 in total
  2 in total

Review 1.  Calcium channel antagonists should be among the first-line drugs in the management of cardiovascular disease.

Authors:  L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1996-09       Impact factor: 3.727

Review 2.  ACE inhibitors and calcium antagonists in the treatment of congestive heart failure.

Authors:  J F Hansen
Journal:  Cardiovasc Drugs Ther       Date:  1995-08       Impact factor: 3.727
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.